Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream
18th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Tag : Alembic pharmaceuticals
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
28 July, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection
30th June, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
17th April, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Alembic Pharmaceuticals successfully completes USFDA inspection of API-III Facility at Karakhadi
24th March, 2025, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States...
Alembic Pharma Reports 4% Revenue Growth; Net Profit at ₹138 Crores in Q3FY25
3rd February 2025, Bengaluru: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter ended...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
15th January, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
20th December, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg.
11th November 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav.
9th October, 2024, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food...